107 related articles for article (PubMed ID: 2477395)
41. AgNOR quantification with special reference to staining patterns.
Rüschoff J; Fauser G; Knüchel R; Hofstädter F
Zentralbl Pathol; 1994 Mar; 140(1):23-30. PubMed ID: 7515669
[TBL] [Abstract][Full Text] [Related]
42. Clinical value of argyrophilic organizer region in bladder transitional cell carcinoma.
Shiina H; Shirakawa H; Yokogi H; Kishi H; Mizutani M; Igawa M; Ishibe T
Urol Int; 1995; 54(2):74-9. PubMed ID: 7747363
[TBL] [Abstract][Full Text] [Related]
43. AgNOR evaluation by image processing methods. Staining modifications and results in 126 invasive ductal breast carcinomas.
Giménez-Mas JA; Gallego-Calvo P; Sanz-Moncasi P; Ríos-Mitchell J; Valero I; Sanz-Anquela M; Burriel J; Bavai A
Anal Quant Cytol Histol; 1996 Feb; 18(1):9-18. PubMed ID: 8851103
[TBL] [Abstract][Full Text] [Related]
44. Lack of prognostic value of nucleolar organizer region enumeration in transitional cell carcinoma of the bladder.
Mansour P; Crocker J; Newman J
Arch Pathol Lab Med; 1990 Dec; 114(12):1261. PubMed ID: 1701296
[TBL] [Abstract][Full Text] [Related]
45. Prognostic significance of nucleolar organizing regions (NORs) in carcinomas of the sigmoid colon and rectum.
Rüschoff J; Bittinger A; Neumann K; Schmitz-Moormann P
Pathol Res Pract; 1990 Feb; 186(1):85-91. PubMed ID: 1690415
[TBL] [Abstract][Full Text] [Related]
46. AgNOR counts are not altered in alcoholic cirrhosis.
Misra V; Misra SP; Dwivedi M; Gupta SC
Indian J Pathol Microbiol; 2003 Apr; 46(2):170-2. PubMed ID: 15022901
[TBL] [Abstract][Full Text] [Related]
47. AgNOR distribution in normal and dysplastic laryngeal mucosa and in laryngeal epidermoid carcinomas.
Mauri FA; Ferrero S; Barbareschi M; Scampini S; Muscarà M; Motta M; Pignataro L
Pathologica; 1990; 82(1081):493-7. PubMed ID: 1706829
[TBL] [Abstract][Full Text] [Related]
48. Ki67 and AgNORs staining in squamous cell carcinoma of the cervix: a comparison.
Chung TK; Cheung TH; Wong FW; Wong YF
Gynecol Obstet Invest; 1994; 37(2):127-9. PubMed ID: 7512064
[TBL] [Abstract][Full Text] [Related]
49. Nucleolar organizer regions in pituitary adenomas.
Radhakrishnan VV; Radhakrishnan NS; Misra BK; Rout D
Indian J Pathol Microbiol; 1995 Jan; 38(1):25-32. PubMed ID: 8919466
[TBL] [Abstract][Full Text] [Related]
50. AgNOR staining of cell imprint preparations of human bladder cancer.
Jinza S; Iki M; Noguchi S; Shuin T; Kubota Y; Takano Y; Masuda M
Acta Cytol; 1996; 40(6):1159-64. PubMed ID: 8960023
[TBL] [Abstract][Full Text] [Related]
51. [Silver-stained Nucleolar Organizer Regions (AgNOR)].
Derenzini M; Trerè D
Pathologica; 2001 Apr; 93(2):99-105. PubMed ID: 11428299
[TBL] [Abstract][Full Text] [Related]
52. Chordoid meningioma: case report and literature review.
Donato G; Ferraro G; Signorelli F; Iofrida G; Lavano A; Amorosi A; Maltese L; Perrotta I; Tripepi S; Pardatscher K; Signorelli CD
Ultrastruct Pathol; 2006; 30(4):309-14. PubMed ID: 16971356
[No Abstract] [Full Text] [Related]
53. Number of nucleoli and nucleolar organizer regions per nucleus and nucleolus--prognostic value in canine mammary tumors.
Bratulić M; Grabarević Z; Artuković B; Capak D
Vet Pathol; 1996 Sep; 33(5):527-32. PubMed ID: 8885179
[TBL] [Abstract][Full Text] [Related]
54. Analysis of silver binding nucleolar organizer regions in exfoliative cytology smears of potentially malignant and malignant oral lesions.
Sowmya GV; Nahar P; Astekar M; Agarwal H; Singh MP
Biotech Histochem; 2017; 92(2):115-121. PubMed ID: 28296547
[TBL] [Abstract][Full Text] [Related]
55. Nucleolar organizer regions (AgNORs) in astrocytic tumors.
Pedal WP; Warzok RW; Hufnagl P; Roth K
Zentralbl Pathol; 1994 Mar; 140(1):89-94. PubMed ID: 7515679
[TBL] [Abstract][Full Text] [Related]
56. Prognostic significance of nucleolar organizer regions in recurrent pleomorphic adenomas of salivary glands.
Criscuolo M; Migaldi M; Collina G; Cesinaro AM; Galetti R; Lo Bianco F; Trentini GP
Pathologica; 1994 Dec; 86(6):606-11. PubMed ID: 7617389
[TBL] [Abstract][Full Text] [Related]
57. [Clinical study on the recurrence of meningiomas: correlating factors for the recurrence and therapeutic prognosis of meningiomas].
Miyagami M; Miyagi A; Kido G; Tsubokawa T
No Shinkei Geka; 1994 May; 22(5):421-8. PubMed ID: 8196827
[TBL] [Abstract][Full Text] [Related]
58. AgNOR counts in conjunctival malignant melanoma lack prognostic value.
Paridaens AD; Seregard S; Minassian D; Hungerford JL; McCartney AC
Br J Ophthalmol; 1992 Oct; 76(10):621-3. PubMed ID: 1420045
[TBL] [Abstract][Full Text] [Related]
59. Prognostic importance of the nucleolar organizer region score in ovarian epithelial tumors.
Zergeroğlu S; Aksakal O; Demirtürk F; Gökmen O
Gynecol Obstet Invest; 2001; 51(1):60-3. PubMed ID: 11150878
[TBL] [Abstract][Full Text] [Related]
60. Standardized AgNOR quantitation.
Ofner D; Schmid KW
J Pathol; 1996 Jun; 179(2):218-9. PubMed ID: 8758216
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
